ARCHIVES

Committee Recommends FDA Approval Of Three New Drugs For Cancer Treatment

This article is from The Cancer Letter archive.

Vol. 24 No. 12 | March 27, 1998

Download PDF Visit The Full Archive

Related Articles

ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay

July 17, 2009

ACS Initiates New Colorectal Cancer Screening Campaign

November 18, 1983

Bosutinib Vs. Imatinib Study Didn’t Meet Primary Endpoint

December 31, 2010

Varmus Appoints Group On Intellectual Property

May 8, 1998

ACCC Seeking Line Item, $21 Million for CCPs; Results Of Evaluation Released

June 5, 1987

NIH Introduces “Modular” Gran Application And Awards

February 26, 1999